NCT04248569 2025-12-03DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular CarcinomaSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 Recruiting56 enrolled